NO20014012L - Inhibitorer for anvendelse i hemostase og immunfunksjon - Google Patents
Inhibitorer for anvendelse i hemostase og immunfunksjonInfo
- Publication number
- NO20014012L NO20014012L NO20014012A NO20014012A NO20014012L NO 20014012 L NO20014012 L NO 20014012L NO 20014012 A NO20014012 A NO 20014012A NO 20014012 A NO20014012 A NO 20014012A NO 20014012 L NO20014012 L NO 20014012L
- Authority
- NO
- Norway
- Prior art keywords
- hemostasis
- inhibitors
- immune function
- related protein
- complement related
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25360499A | 1999-02-19 | 1999-02-19 | |
US44479499A | 1999-11-22 | 1999-11-22 | |
PCT/US2000/004161 WO2000048625A2 (en) | 1999-02-19 | 2000-02-17 | Inhibitors for use in hemostasis and immune function |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20014012D0 NO20014012D0 (no) | 2001-08-17 |
NO20014012L true NO20014012L (no) | 2001-10-02 |
Family
ID=26943406
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20014012A NO20014012L (no) | 1999-02-19 | 2001-08-17 | Inhibitorer for anvendelse i hemostase og immunfunksjon |
Country Status (20)
Country | Link |
---|---|
US (1) | US6448221B1 (pt) |
EP (2) | EP1382345A3 (pt) |
JP (1) | JP2002537270A (pt) |
KR (1) | KR20010102130A (pt) |
CN (1) | CN1341027A (pt) |
AT (1) | ATE245439T1 (pt) |
AU (1) | AU772103B2 (pt) |
BR (1) | BR0008298A (pt) |
CA (1) | CA2361273A1 (pt) |
CZ (1) | CZ20012916A3 (pt) |
DE (1) | DE60004015T2 (pt) |
DK (1) | DK1154785T3 (pt) |
ES (1) | ES2202061T3 (pt) |
HK (1) | HK1039892A1 (pt) |
HU (1) | HUP0105284A3 (pt) |
IL (1) | IL144460A0 (pt) |
NO (1) | NO20014012L (pt) |
PL (1) | PL349924A1 (pt) |
PT (1) | PT1154785E (pt) |
WO (1) | WO2000048625A2 (pt) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6525174B1 (en) | 1997-06-06 | 2003-02-25 | Human Genome Sciences, Inc. | Precerebellin-like protein |
US20040014650A1 (en) * | 2002-07-17 | 2004-01-22 | Sheppard Paul D | Methods for enhancing wound repair |
US6544946B1 (en) * | 1999-02-19 | 2003-04-08 | Zymogenetics, Inc. | Inhibitors for use in hemostasis and immune function |
US8236048B2 (en) | 2000-05-12 | 2012-08-07 | Cordis Corporation | Drug/drug delivery systems for the prevention and treatment of vascular disease |
MY128992A (en) * | 2000-08-25 | 2007-03-30 | Merck Patent Gmbh | Saratin for inhibiting platelet adhesion to collagen |
US8303609B2 (en) | 2000-09-29 | 2012-11-06 | Cordis Corporation | Coated medical devices |
WO2003075848A2 (en) * | 2002-03-08 | 2003-09-18 | Zymogenetics, Inc. | Inhibitors for use in hemostasis |
NO20035748D0 (no) * | 2003-12-19 | 2003-12-19 | Amersham Health As | Optisk avbildning av sårbar arteriosklerose |
US9471978B2 (en) | 2004-10-04 | 2016-10-18 | Banner Health | Methodologies linking patterns from multi-modality datasets |
US7964557B2 (en) * | 2005-03-28 | 2011-06-21 | University Of Louisville Research Foundation, Inc. | Inhibition of wet type age related macular degeneration (AMD) by adiponectin or acrp 30 |
US20090291091A1 (en) * | 2005-07-29 | 2009-11-26 | Laboratoires Serono Sa | Use of the globular domain of acrp30 for the preparation of a medicament for the prevention and/or treatment of thrombosis-related diseases |
WO2008075589A1 (ja) | 2006-12-21 | 2008-06-26 | Chisso Corporation | 血小板凝集惹起物質 |
JP5747370B2 (ja) * | 2009-03-31 | 2015-07-15 | 国立大学法人浜松医科大学 | 高病原性口腔細菌の高感度検出法 |
WO2023215294A1 (en) * | 2022-05-02 | 2023-11-09 | The Board Of Trustees Of The Leland Stanford Junior University | Complement pathway inhibition for wound healing |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5869330A (en) | 1995-06-05 | 1999-02-09 | Whitehead Institute For Biomedical Research | DNA encoding a novel serum protein produced exclusively in adipocytes |
EP1000084A4 (en) | 1997-07-08 | 2003-03-26 | Human Genome Sciences Inc | 123 PROTEIN SEPARATED BY HUMAN |
IL134011A0 (en) * | 1997-07-18 | 2001-04-30 | Zymogenetics Inc | Adipocyte-specific protein homologs |
ES2287979T3 (es) | 1997-08-01 | 2007-12-16 | Serono Genetics Institute S.A. | Est 5' para proteinas secretadas identificadas a partir de tejidos cerebrales. |
EP1009829B1 (en) | 1997-08-26 | 2006-04-26 | ZymoGenetics, Inc. | Adipocyte-specific protein homologs |
DE69837678T2 (de) | 1997-10-29 | 2007-12-27 | Otsuka Pharmaceutical Co., Ltd. | Compositions zur inhibierung der proliferation glatter muskulatur und verfahren zur diagnose von arteriosklerose |
KR100386046B1 (ko) | 1997-12-03 | 2003-06-02 | 제넨테크, 인크. | 폴리펩티드 및 이를 암호화하는 핵산 |
EP1042470A2 (en) | 1997-12-30 | 2000-10-11 | Chiron Corporation | Bone marrow secreted proteins and polynucleotides |
ID27813A (id) | 1998-01-28 | 2001-04-26 | Corixa Corp | Senyawa-senyawa untuk terapi dan diagnosa kanker paru-paru dan metoda untuk penggunaannya |
CA2327317A1 (en) | 1998-04-29 | 1999-11-04 | Genesis Research And Development Corporation Limited | Polynucleotides isolated from skin cells and methods for their use |
WO1999059618A1 (en) | 1998-05-21 | 1999-11-25 | Smithkline Beecham Corporation | Acrp30r1l, a homolog of acrp30 (30 kd adipocyte complement-related protein) |
-
2000
- 2000-02-17 BR BR0008298-8A patent/BR0008298A/pt not_active IP Right Cessation
- 2000-02-17 EP EP03008817A patent/EP1382345A3/en not_active Withdrawn
- 2000-02-17 DK DK00907310T patent/DK1154785T3/da active
- 2000-02-17 US US09/506,855 patent/US6448221B1/en not_active Expired - Fee Related
- 2000-02-17 CZ CZ20012916A patent/CZ20012916A3/cs unknown
- 2000-02-17 IL IL14446000A patent/IL144460A0/xx unknown
- 2000-02-17 KR KR1020017010308A patent/KR20010102130A/ko not_active Application Discontinuation
- 2000-02-17 ES ES00907310T patent/ES2202061T3/es not_active Expired - Lifetime
- 2000-02-17 DE DE60004015T patent/DE60004015T2/de not_active Expired - Fee Related
- 2000-02-17 CN CN00803958A patent/CN1341027A/zh active Pending
- 2000-02-17 PL PL00349924A patent/PL349924A1/xx not_active Application Discontinuation
- 2000-02-17 AT AT00907310T patent/ATE245439T1/de not_active IP Right Cessation
- 2000-02-17 EP EP00907310A patent/EP1154785B1/en not_active Expired - Lifetime
- 2000-02-17 WO PCT/US2000/004161 patent/WO2000048625A2/en not_active Application Discontinuation
- 2000-02-17 JP JP2000599415A patent/JP2002537270A/ja active Pending
- 2000-02-17 PT PT00907310T patent/PT1154785E/pt unknown
- 2000-02-17 CA CA002361273A patent/CA2361273A1/en not_active Abandoned
- 2000-02-17 HU HU0105284A patent/HUP0105284A3/hu unknown
- 2000-02-17 AU AU28832/00A patent/AU772103B2/en not_active Ceased
-
2001
- 2001-08-17 NO NO20014012A patent/NO20014012L/no unknown
-
2002
- 2002-02-15 HK HK02101086.1A patent/HK1039892A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
DE60004015D1 (de) | 2003-08-28 |
IL144460A0 (en) | 2002-05-23 |
US6448221B1 (en) | 2002-09-10 |
EP1154785A2 (en) | 2001-11-21 |
HUP0105284A2 (hu) | 2002-05-29 |
DE60004015T2 (de) | 2004-04-15 |
DK1154785T3 (da) | 2003-11-17 |
CN1341027A (zh) | 2002-03-20 |
HUP0105284A3 (en) | 2003-12-29 |
CZ20012916A3 (cs) | 2002-05-15 |
PT1154785E (pt) | 2003-12-31 |
EP1382345A3 (en) | 2004-01-28 |
JP2002537270A (ja) | 2002-11-05 |
BR0008298A (pt) | 2002-02-19 |
ATE245439T1 (de) | 2003-08-15 |
ES2202061T3 (es) | 2004-04-01 |
AU772103B2 (en) | 2004-04-08 |
CA2361273A1 (en) | 2000-08-24 |
AU2883200A (en) | 2000-09-04 |
EP1382345A2 (en) | 2004-01-21 |
PL349924A1 (en) | 2002-10-21 |
NO20014012D0 (no) | 2001-08-17 |
WO2000048625A2 (en) | 2000-08-24 |
EP1154785B1 (en) | 2003-07-23 |
WO2000048625A3 (en) | 2000-12-28 |
HK1039892A1 (zh) | 2002-05-17 |
KR20010102130A (ko) | 2001-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20014012D0 (no) | Inhibitorer for anvendelse i hemostase og immunfunksjon | |
DE60236413D1 (de) | Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten | |
AU5056196A (en) | Hydrogel-forming, self-solvating absorbable polyester copolymers and methods for use thereof | |
NZ263344A (en) | Human bactericidal/permeability increasing (bpi) protein functional domain peptides and their use | |
DK1918298T3 (da) | Peptid | |
DK0913156T3 (da) | Anvendelse af aktiveret protein C til behandling af hyperkoagulationstilstande i forbindelse med sepsis | |
ATE245977T1 (de) | Therapeutische substituierte guanidine | |
NO20013608L (no) | DNA-klon for human vevsfaktorinhibitor | |
IS5591A (is) | Grunnmassaprótínsamsetningar til sáragræðslu | |
DE60020681D1 (de) | Zusammensetzungen und verfahren zur verbesserung der integrität von angegriffenen körperpassagewegen und höhlen | |
GB9930768D0 (en) | Composition | |
DK0643585T3 (da) | Anvendelsen af lipoprotein-associeret koagulationsinhibitor (LACI) til fremstilling af et lægemiddel til behandlingen af ak | |
EA200200853A1 (ru) | Применение 2-метилтиазолидин-3,3-дикарбоновой кислоты (2-мтдк) и/или ее физиологически совместимых солей для лечения и/или предупреждения рака | |
NO20021410D0 (no) | Forebygging og behandling av blodkoagulasjons-relaterte sykdommer | |
ATE312179T1 (de) | Serin-threonin-kinase enthaltendes mittel zur tumortherapie und tumordiagnose | |
DE69737088D1 (de) | Therapeutisches agens zur behandlung von fiv infektionen | |
DE60011601D1 (de) | Rekombinantes sp-a zur behandlung und vorbeugung von pulmonaren infektionen und entzündungen | |
DE60139574D1 (de) | Kombination von aktiviertem factor viia und fibrinogen und verwendung zur behandlung von blutung | |
DE50207168D1 (de) | Kombinationspräparat zur Therapie von immunologischen Erkrankungen | |
GEP19991605B (en) | Inhibitor, Its Obtaining and Use | |
UA37445A (uk) | Протизапальний засіб | |
RU94025749A (ru) | Способ оперативного лечения дуоденостаза | |
UA9703A (uk) | Антипротеіназний засіб | |
ITMI931616A0 (it) | Chiodo endomidollare per uso in osteosintesi per il trattamento chirurgico delle fratture diafisometafisarie di femore e di tibia. |